{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:24:58Z","timestamp":1785324298482,"version":"3.55.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute","award":["5R01CA226211-03"],"award-info":[{"award-number":["5R01CA226211-03"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Androgen deprivation therapy (ADT), a cornerstone of treatment for patients with locally advanced and metastatic prostate cancer, is associated with many adverse effects, including osteoporosis, sexual dysfunction, fatigue, and vasomotor symptoms. It is also associated with loss of muscle mass and increased adiposity. This change in body composition is likely the inciting event in the development of insulin resistance, an independent risk factor for diabetes mellitus and cardiovascular disease. Although the occurrence of insulin resistance during ADT has been reported, it remains unclear whether this insulin resistance is primarily hepatic or muscular. Similarly, the mechanisms that lead to insulin resistance also remain unknown. The ADT &amp; Metabolism Study was designed to address these knowledge gaps, as the elucidation of the predominant site of insulin resistance will allow prevention strategies and the use of targeted, tissue-specific insulin-sensitizing agents in patients undergoing ADT. This prospective, mechanistic, single-center, 24-week, observational cohort study will enroll treatment-na\u00efve adult men with prostate cancer about to undergo surgical or medical ADT for at least 24 weeks (ADT group; n = 50) and a control group of men who had undergone radical prostatectomy and are in remission (non-ADT group, n = 25). The primary outcome is to determine the site of insulin resistance (skeletal muscle or liver) using frequent sampling oral glucose tolerance test at baseline and 12 and 24 weeks after commencement of ADT (ADT group) or after enrollment in the study (non-ADT group). Secondary outcomes will assess changes in hepatic and intramyocellular fat (using magnetic resonance spectroscopy), inflammatory markers, adipokines, free fatty acids, and changes in body composition (assessed using dual-energy x-ray absorptiometry) and their correlation with the development of insulin resistance. Exploratory outcomes will include changes in muscle performance, physical function, physical activity, vitality, and sexual drive.<\/jats:p>","DOI":"10.1371\/journal.pone.0281508","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T18:42:58Z","timestamp":1676054578000},"page":"e0281508","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT &amp; Metabolism Study): Protocol of a longitudinal, observational, cohort study"],"prefix":"10.1371","volume":"18","author":[{"given":"Milena","family":"Braga-Basaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Travison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Ellen","family":"Taplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8236-880X","authenticated-orcid":true,"given":"Alexander","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa B.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-0214","authenticated-orcid":true,"given":"Daniel","family":"Habtemariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Kibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praful","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richelle","family":"Bearup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0567-9222","authenticated-orcid":true,"given":"Hussein","family":"Kafel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Storer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Simonson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-8549","authenticated-orcid":true,"given":"Shehzad","family":"Basaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"pone.0281508.ref001","volume-title":"Cancer facts & figures","author":"American Cancer Society"},{"key":"pone.0281508.ref002","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","article-title":"Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland","volume":"43","author":"C SRJ Huggins","year":"1941","journal-title":"Arch Surg"},{"issue":"9","key":"pone.0281508.ref003","first-page":"687","article-title":"Endocrine complications of androgen-deprivation therapy in men with prostate cancer","volume":"4","author":"LK Harle","year":"2006","journal-title":"Clin Adv Hematol Oncol"},{"issue":"6","key":"pone.0281508.ref004","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2002.01551.x","article-title":"Long-term effects of androgen deprivation therapy in prostate cancer patients","volume":"56","author":"S Basaria","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"pone.0281508.ref005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2010.03942.x","article-title":"Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy","volume":"74","author":"EJ Hamilton","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"pone.0281508.ref006","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s001250050581","article-title":"Insulin resistance and coronary artery disease","volume":"39","author":"P Bressler","year":"1996","journal-title":"Diabetologia"},{"issue":"1A","key":"pone.0281508.ref007","doi-asserted-by":"crossref","first-page":"11J","DOI":"10.1016\/S0002-9149(99)00351-3","article-title":"Epidemiology of insulin resistance and its relation to coronary artery disease","volume":"84","author":"SM Haffner","year":"1999","journal-title":"Am J Cardiol"},{"issue":"7","key":"pone.0281508.ref008","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diacare.25.7.1177","article-title":"Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study","volume":"25","author":"AJ Hanley","year":"2002","journal-title":"Diabetes Care"},{"issue":"5","key":"pone.0281508.ref009","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc13-2668","article-title":"Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease","volume":"37","author":"FB Kraemer","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0281508.ref010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1479164111403170","article-title":"Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk","volume":"8","author":"MR Salazar","year":"2011","journal-title":"Diab Vasc Dis Res"},{"issue":"5","key":"pone.0281508.ref011","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.mcna.2011.06.002","article-title":"Insulin resistance: the link between obesity and cardiovascular disease","volume":"95","author":"GM Reaven","year":"2011","journal-title":"Med Clin North Am"},{"issue":"11","key":"pone.0281508.ref012","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.2337\/dc13-0520","article-title":"Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk","volume":"36","author":"RA Defronzo","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"pone.0281508.ref013","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.21642","article-title":"Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy","volume":"106","author":"S Basaria","year":"2006","journal-title":"Cancer"},{"issue":"24","key":"pone.0281508.ref014","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"M Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"pone.0281508.ref015","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archinte.167.6.612","article-title":"Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer","volume":"167","author":"S Basaria","year":"2007","journal-title":"Arch Intern Med"},{"issue":"6","key":"pone.0281508.ref016","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.2007-2595","article-title":"Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis","volume":"93","author":"S Shahani","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"pone.0281508.ref017","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/CIRCULATIONAHA.107.740365","article-title":"Testosterone making an entry into the cardiometabolic world","volume":"116","author":"S Basaria","year":"2007","journal-title":"Circulation"},{"issue":"9","key":"pone.0281508.ref018","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1210\/jcem.86.9.7851","article-title":"The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer","volume":"86","author":"JC Smith","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0281508.ref019","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20020209","article-title":"Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia","volume":"104","author":"F Dockery","year":"2003","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"pone.0281508.ref020","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2005-2507","article-title":"Insulin sensitivity during combined androgen blockade for prostate cancer","volume":"91","author":"MR Smith","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"pone.0281508.ref021","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1180::AID-CNCR18>3.0.CO;2-1","article-title":"Cause of death in men diagnosed with prostate carcinoma","volume":"83","author":"WA Satariano","year":"1998","journal-title":"Cancer"},{"issue":"6","key":"pone.0281508.ref022","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/01.ju.0000127740.96006.1a","article-title":"Changing patterns in competing causes of death in men with prostate cancer: a population based study","volume":"171","author":"G Lu-Yao","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"pone.0281508.ref023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"102","author":"NL Keating","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"pone.0281508.ref024","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.eururo.2012.01.045","article-title":"Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism","volume":"61","author":"JC Hu","year":"2012","journal-title":"Eur Urol"},{"issue":"1A","key":"pone.0281508.ref025","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1016\/S0002-9343(98)00207-1","article-title":"Type 2 diabetes care: the role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention","volume":"105","author":"RR Henry","year":"1998","journal-title":"Am J Med"},{"issue":"1","key":"pone.0281508.ref026","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2337\/db07-1839","article-title":"Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues","volume":"58","author":"H Wang","year":"2009","journal-title":"Diabetes"},{"issue":"1","key":"pone.0281508.ref027","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00125-007-0867-x","article-title":"Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome","volume":"51","author":"A Kotronen","year":"2008","journal-title":"Diabetologia"},{"issue":"7","key":"pone.0281508.ref028","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","article-title":"Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men","volume":"87","author":"A Seppala-Lindroos","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"pone.0281508.ref029","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.amjmed.2006.01.009","article-title":"Etiology of insulin resistance","volume":"119","author":"KF Petersen","year":"2006","journal-title":"Am J Med"},{"issue":"3","key":"pone.0281508.ref030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3322\/caac.20061","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology","volume":"60","author":"GN Levine","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"pone.0281508.ref031","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice C","year":"2022","journal-title":"Diabetes Care"},{"issue":"9","key":"pone.0281508.ref032","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"M Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"pone.0281508.ref033","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc06-1519","article-title":"Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test","volume":"30","author":"MA Abdul-Ghani","year":"2007","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"pone.0281508.ref034","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1038\/oby.2006.280","article-title":"New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy","volume":"14","author":"KF Petersen","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"pone.0281508.ref035","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"LS Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"pone.0281508.ref036","first-page":"A118","article-title":"The Rapid Assessment of Physical Activity (RAPA) among older adults","volume":"3","author":"TD Topolski","year":"2006","journal-title":"Prev Chronic Dis"},{"key":"pone.0281508.ref037","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cct.2017.05.004","article-title":"Design of a randomized trial to determine the optimum protein intake to preserve lean body mass and to optimize response to a promyogenic anabolic agent in older men with physical functional limitation","volume":"58","author":"S Bhasin","year":"2017","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"pone.0281508.ref038","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.aje.a114086","article-title":"Reproducibility and validity of a semiquantitative food frequency questionnaire","volume":"122","author":"WC Willett","year":"1985","journal-title":"Am J Epidemiol"},{"issue":"10","key":"pone.0281508.ref039","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a116211","article-title":"Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals","volume":"135","author":"EB Rimm","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"5","key":"pone.0281508.ref040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ajcn\/78.5.941","article-title":"Reproducibility and validity of the Diet Quality Index Revised as assessed by use of a food-frequency questionnaire","volume":"78","author":"PK Newby","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"pone.0281508.ref041","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1210\/jc.2002-021231","article-title":"Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension","volume":"88","author":"TW Storer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0281508.ref042","first-page":"583","article-title":"Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men","volume":"102","author":"TW Storer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"pone.0281508.ref043","first-page":"919","article-title":"The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure","volume":"132","author":"GH Guyatt","year":"1985","journal-title":"Can Med Assoc J"},{"issue":"6","key":"pone.0281508.ref044","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/gerona\/glz167","article-title":"The Stair Climb Power Test as an Efficacy Outcome in Randomized Trials of Function Promoting Therapies in Older Men","volume":"75","author":"T Gagliano-Juca","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"pone.0281508.ref045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/ijcp.12542","article-title":"Establishing the content validity of the Sexual Arousal, Interest, and Drive Scale and the Hypogonadism Energy Diary","volume":"69","author":"RP Hayes","year":"2015","journal-title":"Int J Clin Pract"},{"issue":"3","key":"pone.0281508.ref046","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/aje\/kwi187","article-title":"When is baseline adjustment useful in analyses of change? An example with education and cognitive change","volume":"162","author":"MM Glymour","year":"2005","journal-title":"Am J Epidemiol"},{"key":"pone.0281508.ref047","author":"LN Fitzmaurice GM","year":"2004","journal-title":"Applied Longitudinal Analysis Wiley-Interscience"},{"issue":"6","key":"pone.0281508.ref048","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0962280211427759","article-title":"Extension of the modified Poisson regression model to prospective studies with correlated binary data","volume":"22","author":"GY Zou","year":"2013","journal-title":"Stat Methods Med Res"},{"issue":"7121","key":"pone.0281508.ref049","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"GS Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"7","key":"pone.0281508.ref050","doi-asserted-by":"crossref","first-page":"E1182","DOI":"10.1210\/jc.2011-2963","article-title":"Skeletal muscle lipid peroxidation and insulin resistance in humans","volume":"97","author":"KH Ingram","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"pone.0281508.ref051","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","article-title":"Tumor necrosis factor alpha inhibits signaling from the insulin receptor","volume":"91","author":"GS Hotamisligil","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"pone.0281508.ref052","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s00125-012-2597-y","article-title":"Revisiting the connection between intramyocellular lipids and insulin resistance: a long and winding road","volume":"55","author":"DM Muoio","year":"2012","journal-title":"Diabetologia"},{"issue":"5","key":"pone.0281508.ref053","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"GS Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0281508.ref054","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"A Kotronen","year":"2008","journal-title":"Gastroenterology"},{"issue":"5091","key":"pone.0281508.ref055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"GS Hotamisligil","year":"1993","journal-title":"Science"},{"issue":"3","key":"pone.0281508.ref056","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11892-008-0032-z","article-title":"Ectopic fat and insulin resistance","volume":"8","author":"A Lettner","year":"2008","journal-title":"Curr Diab Rep"},{"issue":"3","key":"pone.0281508.ref057","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.juro.2018.03.135","article-title":"Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer","volume":"200","author":"P Gild","year":"2018","journal-title":"J Urol"},{"issue":"24","key":"pone.0281508.ref058","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"DH Solomon","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"pone.0281508.ref059","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1210\/jc.2010-1170","article-title":"TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome","volume":"96","author":"TL Stanley","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"pone.0281508.ref060","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archinte.166.8.902","article-title":"Effects of etanercept in patients with the metabolic syndrome","volume":"166","author":"LE Bernstein","year":"2006","journal-title":"Arch Intern Med"},{"issue":"2","key":"pone.0281508.ref061","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.urology.2008.03.032","article-title":"Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy","volume":"72","author":"K Bylow","year":"2008","journal-title":"Urology"},{"issue":"4","key":"pone.0281508.ref062","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.urology.2010.11.024","article-title":"Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study","volume":"77","author":"K Bylow","year":"2011","journal-title":"Urology"},{"issue":"1","key":"pone.0281508.ref063","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/gerona\/gls078","article-title":"The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men","volume":"68","author":"S Basaria","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T18:43:44Z","timestamp":1676054624000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281508"}},"subtitle":[],"editor":[{"given":"Dario","family":"Ummarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0281508","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}